RECRUITING

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study evaluates the implementation of evidence based strategies to optimize HPV vaccination in rural primary care settings. Some of the largest disparities in human papillomavirus vaccination (HPVV) rates exist in rural communities, which represent missed opportunities for cancer prevention. Primary care provider visits in these communities serve as a crucial opportunity to communicate the importance of timely vaccination that is essential to effective cancer prevention. This study implements and tests a practice-level intervention (PC TEACH) using practice facilitation of evidence-based strategies to expand reach to rural community-based primary care settings to optimize delivery and increase HPVV rates. PC TEACH program may help rural communities overcome access and awareness factors that keep them from receiving HPVV.

Official Title

Implementation of Evidence-Based Strategies to Optimize HPV Vaccination in Rural Primary Care Settings

Quick Facts

Study Start:2023-05-24
Study Completion:2028-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06256718

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * PRACTICES: Are located in the 20-county target region
  2. * PRACTICES: Have an adolescent patient population \>= 150 (aged 9-18)
  3. * PRACTICES: Administer adolescent vaccines (e.g., HPV, Tdap, MCV4)
  4. * PRACTICES: Are willing to share aggregate practice and patient-level data (e.g., electronic health record \[EHR\], surveys)
  5. * PARTICIPANTS: Medical providers and medical staff \>= 18 years of age
  6. * PARTICIPANTS: Primary care providers and medical office staff who deliver adolescent care at community-based primary care practice sites across 20 rural counties in central and western New York
  7. * PARTICIPANTS: Age \>= 18 years of age (no upper limit)
  8. * PARTICIPANTS: English speaking
  9. * PARENT/GUARDIAN SURVEY: Adult accompanying a child or children aged 9 to 17
  10. * PARENT/GUARDIAN SURVEY: English speaking
  11. * PARENT/GUARDIAN SURVEY: Presenting to the participating clinic for an outpatient well child visit or regular checkup
  12. * PARENT/GUARDIAN SURVEY: Willing to complete an anonymous survey while visiting the clinic
  1. * Unwilling or unable to follow protocol requirements
  2. * Adults unable to complete study measures in English
  3. * Individuals who are not yet adults (infants, children, teenagers)
  4. * Cognitively impaired adults/adults with impaired decision-making capacity
  5. * Prisoners

Contacts and Locations

Principal Investigator

Elisa Rodriguez
PRINCIPAL_INVESTIGATOR
Roswell Park Cancer Institute

Study Locations (Sites)

Roswell Park Cancer Institute
Buffalo, New York, 14263
United States

Collaborators and Investigators

Sponsor: Roswell Park Cancer Institute

  • Elisa Rodriguez, PRINCIPAL_INVESTIGATOR, Roswell Park Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-05-24
Study Completion Date2028-04-30

Study Record Updates

Study Start Date2023-05-24
Study Completion Date2028-04-30

Terms related to this study

Additional Relevant MeSH Terms

  • Human Papillomavirus Infection